PRKAA2 and metabolic syndrome: Over the past decades, much work has emerged to support the beneficial role of AMPK in chronic inflammatory disorders such as metabolic syndrome and inflammatory diseases (Cheang et al., 2014; Guma et al., 2015; Kjøbsted et al., 2015).